Core Viewpoint - The company has signed a mortgage contract with its controlling shareholder, Chengdu Xingcheng Investment Group, and completed the mortgage procedures, using its assets to provide collateral valued at over 10% of the company's audited net assets for 2024 [1] Group 1 - The company has entered into a mortgage agreement with Chengdu Xingcheng Investment Group [1] - The mortgage procedures have been completed recently [1] - The collateral provided by the company exceeds 10% of its audited net assets for the year 2024 [1]

腾讯云AI漫剧解决方案支持腾讯混元等众多头部大模型的一站式接入，通过独有的Prompt提示词优化与 多图参考技术，有效解决AI生成漫剧中人物长相不统一、画风突变的行业难题。同时，无论是将真人 短剧一键转化为动漫风格的"视频转绘"，还是基于图片的"PPT漫"，抑或是全AI生成的动态漫，该方案 均提供了成熟的场景化模板，大幅降低了制作门槛。 近日，腾讯云并推出一站式AI漫剧解决方案。该方案深度融合了腾讯云领先的AIGC生成能力与媒体处 理MPS技术，旨在解决漫剧行业普遍面临的生产和运营痛点，助力企业实现从剧本创作、视频生成到全 球化宣发的全链路提质增效。 针对AI漫剧制作中最为复杂的资产生成环节，腾讯云AI漫剧解决方案覆盖了从剧本生成、角色库搭 建、分镜绘制、AI配音、视频生成、画质增强的全流程自动化、智能化。 另外，AI生成的原始视频往往存在分辨率较低、画面崩坏等问题。通过腾讯云媒体处理MPS能力，可 以智能修复与增强AI生成内容，并且实现组合式降本。比如，依托大模型对视觉规律的深度解构，系 统能自动识别并重绘画面中的"崩坏点"，实现发丝级细节还原和光影逻辑修复。而且，通过"AIGC生成 低分辨率视频+腾讯云媒 ...

2025年5月下旬，港股三生制药股价单日暴涨超30%，子公司三生国健在A股市场更是连续四个交易日 斩获"20CM"涨停。点燃这场资本狂欢导火索的，是一笔高达60.5亿美元的对外授权合作交易——辉瑞 拿下其抗癌双抗药物SSGJ-707海外权益，仅首付款就达到12.5亿美元。 而这，仅仅只是拉开了全年BD热潮的序幕。 从三生制药和辉瑞的双抗交易刷新国内BD首付款记录开始，信达生物、舶望制药、恒瑞医药 （600276）等公司接连宣布与武田、诺华、GSK等跨国药企达成数十亿乃至上百亿美元的合作。 过去一年，"BD"无疑是医药行业贯穿全年的核心关键词。据医药魔方研报数据披露，2025年国内创新 药对外授权交易总交易额超1300亿美元，仅首付款就超70亿美元，在ADC、双抗、GLP-1等前沿赛道 上，更是展现出影响细分赛道未来格局的潜力。 除了金额的飙升，BD交易模式的演变同样反映出产业关系的变迁。从单纯的licenseout到New-Co和Co- co模式（共同开发、共同商业化），乃至于共建"风险共担、利益共享"的生态，从单纯的"卖产 品"到"卖平台"，传统药企强势崛起，中小biotech多点开花。 刘立鹤同样提到，相 ...

杏仁饮料的矩阵成员，早已不止是杏仁露。从大单品延伸为一种风味符号，胶原蛋白肽、椰子、抹茶等多重元素，均在外化"杏仁＋"这一赛道的潜在机遇。 剖析当下植物蛋白饮品新品类的成功密码，创健投资集团在公众号研报中提到，有三大驱动力正拓宽植物蛋白饮料赛道的想象空间，分别是"节令风味=新 饮品爆款发动机"、"花果香+轻乳感=年轻人高复购模型"、"植物×地方记忆=品类共鸣感正在形成"。 但品类扩张不仅是植物蛋白饮料竞争跃迁的重要一环，也是起点之一。展望未来，中研普华产业研究院在研报中还提到行业生态构建的完善。具体来看，研 报显示，植物蛋白饮料行业的终局竞争，将超越单一产品维度，转向"健康生态"的构建，功能化升级便是之一，添加益生菌、胶原蛋白的"美容型植物奶"已 在一线城市试水，客单价突破15元/瓶。此外，可持续发展与数智化突围也指明了行业前进方向。就前者而言，采用碳中和包装(如椰壳纤维瓶)的品牌，在 ESG投资框架下更易获得资本青睐；对于后一趋势，AI驱动的C2M定制模式将重构供应链，实现"千人千饮"。 图片来源：企业小红书官方账号截图 "大窑饮品推出醇香杏仁露，既是基于对饮料消费趋势的把握，也是对'1（碳酸）+2（果汁& ...

近日，微电生理发布公告称，公司的磁导航消融导管及星型高密度标测导管于近日获得了欧盟医疗器械 法规（MDR）认证证书。 此次认证将助力公司进入欧洲市场，依托高附加值产品进一步扩大海外收入规模，并完善海外"标测 +消融"技术矩阵。 ...

近日，华润医药发布公告称，公司全资附属公司华润医药投资有限公司及其附属公司拟通过公开挂牌方 式，出售合肥天麦生物科技发展有限公司约17.87%股权，挂牌底价约14.2亿元。截至本公告日，华润医 药投资及其附属公司持有天麦生物科技少于30%股权。 ...

Group 1 - The company, Asia-Pacific Pharmaceutical (002370), announced a change in control, leading to the resignation of key executives including the General Manager, Secretary of the Board, and Chief Financial Officer [1] - The resignations are effective immediately upon delivery of their written resignation reports to the company's board of directors [1] - The executives who resigned, namely Cen Jianwei, Xu Wei, and Xu Jingyang, do not hold any shares in the company and have no outstanding commitments to fulfill [2]

Core Viewpoint - Hualan Co., Ltd. announced a collaboration between its wholly-owned subsidiary, Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd., and a technical team led by former CTO of Insilico Liu Kaixian and Academician Liu Jun from the American Academy of Sciences to establish a joint venture focused on drug repurposing and pharmacovigilance services using knowledge graphs [1][2]. Group 1 - The joint venture will be controlled by Lingqing Smart and will be included in the company's consolidated financial statements [1]. - The venture aims to provide intelligent solutions for drug research and safety management by integrating heterogeneous data sources [1]. - The specific business scope will be defined according to the business registration information [1]. Group 2 - To enhance the long-term development motivation of the joint venture, the company plans to implement a performance-based partnership incentive arrangement linked to business targets [2]. - This incentive will involve transferring partnership shares through Holding Platform 1 to motivate key personnel and others who significantly contribute to the joint venture's development [2]. - The arrangement aims to align the interests of core personnel with the long-term success of the venture, promoting risk-sharing and long-term incentives [2].

Core Insights - The company, Haoxiangni (002582), announced that its flagship store located on Huanghe Road in Zhengzhou achieved over 1 million sales in its first week of operation, marking a significant milestone for the store [1] Company Performance - The flagship store's sales performance indicates strong market demand and effective business strategy, as it reached the milestone of 1 million in sales faster than any other single store [1]

近日，费大厨宣布春节不打烊，全国门店正常营业，具体营业时间以商场营业时间为准。考虑到春节期 间客流变化情况，费大厨多方着手积极应对，相关的应对措施节前已预演排练，目前各门店人员储备充 足，能够完全满足顾客的就餐需求。同时，门店的新鲜食材储备也会比平时增加30%以上。 ...